Drugs & Treatments

/Drugs & Treatments

Erleada- New Treatment for Non-Metastatic Castrate Resistant Prostate Cancer

Erleada (apalutamide) has just received FDA approval as a drug for treating men with non-metastatic castration-resistant prostate cancer.   The proper pronunciation is Er ( Errr), (Like Her without the h) ) (lee) (long E) da. Now, repeat after me, "Erleada!" It's a pill that you take - I believe - four times a [...]

Prostate Cancer Treatment Options

Men with Prostate Cancer May Not Know All Of Their Treatment Options and Risks by Brian Miles, MD  Urology Houston Methodist Urology Associates Professor of Urology, Institute for Academic Medicine Houston Methodist - Weill Cornell Medical College According to a September 2017 study by BJU International, men who have been diagnosed with localized prostate [...]

By |2018-01-29T08:51:47+00:00January 26th, 2018|Drugs & Treatments, General Information|1 Comment

An Easier, Cheaper and More Comfortable Way To Take Zytiga

Rather than taking – and paying – for the full Zytiga dose on an empty stomach, ask your doctor if you could get the same effect from taking just one fourth of your Zytiga dose while enjoying a low-fat or high-fat breakfast. A small phase two study of 36 prostate cancer patients who took 250 [...]

Ask For a Blood test to identify AR-V7 in Circulating Tumor Cells if you are starting Xtandi or Zytiga

One of the hot topics in the prostate cancer community is the value of detecting AR-V7 tumor cells circulating in the blood. AR-V7 tumor cells in the blood predicts response or failure of treatment with enzalutamide (Xtandi) or abiraterone (Zytiga). A recent study found that men who have AR-V7 circulating tumor cells in their blood will not [...]

Men Who Fail Primary Radiation Can Have Good Results After Salvage Surgery

Men who have decided to have radiation as their first (primary) treatment for prostate cancer have a one-third chance of recurrence. Some of those men have salvage radical prostatectomy (SRP)  to fight the recurrence.  A study shows this might be a good idea. Antoni Vilaseca, MD, etal from Memorial Sloan-Kettering Cancer Center in New York, studied 251 men [...]

New Investigational Treatment Instead of Active Surveillance & Maybe for Distant Tumors

Today’s post is not directly an advanced prostate cancer post, but more about a new potential and very interesting treatment on the horizon for men with prostate cancer that might otherwise be considered for active surveillance. According to the researchers who have been working on the treatment protocol, it is "truly transformative". This is not [...]

Understanding the Confusion Around Drug Names

Drugs and their names are just confusing. When they are being developed they are given many different names. Despite their names the drugs (or treatments) are the same. Names are just names nothing more. For laymen, drugs having multiple names for the same drug is confusing. So, why are there so many different names for [...]

Xtandi In Combination with Zytiga Is Not Better Than Either Drug Alone

Often I have heard people ask why if one drug is effective we shouldn’t simply take two or three at the same time? The answer is simple, because we don’t know if combining multiple drugs will make any difference to a man’s survival. The only way we can be sure is with good evidence. Good [...]

One Man’s Shares His Personal Tips About Having Provenge To Treat His Advanced Prostate Cancer

The following was posted on the Malecare Advanced Prostate Cancer Health Unlocked online support group.  I have received permission to reprint it here because it might be helpful to some of you. FYI-    Provenge is a cancer vaccine that helps to mobilize your own immune system to your prostate cancer.  It is currently only [...]

Cognition and Hormone Therapy (ADT)

There have been numerous studies examining the how hormone deprivation (ADT), in the treatment of prostate cancer, has on a man’s cognition. There have been contradictor studies about this issue, however having had the experience and the honor of dealing with so many men with prostate cancer treated with androgen deprivation therapy (ADT), as well [...]